The estimated net worth of Jeffrey C. Pepe is at least $198K dollars as of 08 Sep 2022. Jeffrey C. Pepe is the Interim CEO and GC of Silverback Therapeutics, Inc. and owns shares of ARS Pharmaceuticals, Inc. (SPRY) stock worth about $198K.
There are no insider transactions reported by Jeffrey C. Pepe
We use cookies and similar technologies to provide certain features, enhance
the user experience and deliver content that is relevant to your interests.
Depending on their purpose, analysis and marketing cookies may be used in
addition to technically necessary cookies. By clicking on "Agree and
continue", you declare your consent to the use of the aforementioned cookies.
Here
you can make detailed settings or revoke your consent (in part if necessary)
with effect for the future. For further information, please refer to our
Privacy Policy
.